NEW TAIPEI CITY, TAIWAN — The Medical and Pharmaceutical Industry Technology and Development Center (PITDC) extended a warm welcome to Duo Pharma, Malaysia's largest pharmaceutical company, during an official delegation visit on March 17. The visit facilitated in-depth exchanges on industrial cooperation between the Taiwanese and Malaysian pharmaceutical sectors, marking a significant step toward deeper bilateral integration.

During the visit, representatives from both sides engaged in comprehensive discussions regarding current drug registration regulations, regulatory review processes, and market access mechanisms in their respective regions. The constructive and highly positive dialogue allowed both parties to explore viable opportunities for future collaboration, successfully establishing a robust foundation for a closer strategic partnership.

PITDC highlighted that the Southeast Asian market remains a critical strategic focus for Taiwan's pharmaceutical industry as it expands its global footprint. The visit from such a leading, benchmark pharmaceutical company carries high symbolic significance. It not only fosters mutual trust between the industries of both nations but also lays an excellent groundwork for subsequent substantive business partnerships and technology exchanges.

Looking ahead, PITDC is committed to leveraging its extensive industry resources and the deep expertise of its professional teams to bridge the upstream and downstream sectors of the supply chain. By continuing to drive cross-border collaboration opportunities, PITDC aims to further elevate the global competitiveness of Taiwanese pharmaceutical products and continue achieving outstanding milestones in international export performance.